La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Medifast Bilan de santé
Santé financière contrôle des critères 6/6
Medifast possède un total de capitaux propres de $205.3M et une dette totale de $0.0, ce qui porte son ratio d'endettement à 0%. Son actif total et son passif total sont $293.5M et de $88.2M. L'EBIT de Medifast est $34.2M ce qui fait que son ratio de couverture des intérêts -7.2. Elle dispose de liquidités et de placements à court terme de $163.5M.
Informations clés
0%
Ratio d'endettement
US$0
Dette
| Ratio de couverture des intérêts | -7.2x |
| Argent liquide | US$163.51m |
| Fonds propres | US$205.28m |
| Total du passif | US$88.25m |
| Total des actifs | US$293.53m |
Mises à jour récentes de la santé financière
Recent updates
Medifast: GLP-1 Fears Are Overblown, But Proof Points For Turnaround Are Still Missing
Jun 26Medifast: Significant Undervaluation Even As Struggles Persist
May 24At US$22.76, Is Medifast, Inc. (NYSE:MED) Worth Looking At Closely?
May 24
Lacklustre Performance Is Driving Medifast, Inc.'s (NYSE:MED) 32% Price Drop
May 24Medifast's (NYSE:MED) Conservative Accounting Might Explain Soft Earnings
May 06The Returns On Capital At Medifast (NYSE:MED) Don't Inspire Confidence
May 01Medifast: Cheap Valuation, Uncertain Future
Mar 20Medifast Is Getting Attractive
Mar 07Medifast, Inc.'s (NYSE:MED) 26% Dip In Price Shows Sentiment Is Matching Earnings
Feb 22Medifast Share Price Loses Weight, But Is There Still Value To Be Had?
Jan 20Are Investors Undervaluing Medifast, Inc. (NYSE:MED) By 47%?
Dec 09Medifast: Good On Paper, But A Slowdown In Sales Is Very Worrisome
Nov 24Is It Too Late To Consider Buying Medifast, Inc. (NYSE:MED)?
Nov 21Medifast: Unveiling A Challenge Beyond Weight Loss Drugs
Nov 09Medifast: The Race To Weight-Loss Drugs Not Lost Yet
Oct 09Medifast: Take Advantage Of Pessimism Over Weight Loss Drugs
Aug 04Is Now An Opportune Moment To Examine Medifast, Inc. (NYSE:MED)?
Jul 26In The Murky MLM Space, Medifast Might Actually Hold Some Promise
Jul 21Estimating The Intrinsic Value Of Medifast, Inc. (NYSE:MED)
Jul 05Medifast: In Survival Mode Against Diet Pills And The Recession
Jun 14Medifast Holds Value During Headwinds
May 28Medifast Non-GAAP EPS of $3.70 beats by $1.48, revenue of $337.2M beats by $7.1M
Feb 21Medifast: A Low Earnings Multiple Despite Strong Financial Performance
Feb 07At US$117, Is Medifast, Inc. (NYSE:MED) Worth Looking At Closely?
Jan 19Medifast declares $1.64 dividend
Dec 08A Look At The Intrinsic Value Of Medifast, Inc. (NYSE:MED)
Dec 01Medifast's (NYSE:MED) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Nov 10One Medifast, Inc. (NYSE:MED) Analyst Just Made A Major Cut To Next Year's Estimates
Nov 08Medifast: This High-Yield Blue Chip Dividend Stock Is A Strong Buy
Nov 06What Does Medifast, Inc.'s (NYSE:MED) Share Price Indicate?
Oct 20We Think Medifast (NYSE:MED) Can Stay On Top Of Its Debt
Sep 18Medifast declares $1.64 dividend
Sep 08Do Medifast's (NYSE:MED) Earnings Warrant Your Attention?
Sep 02Medifast: Let's Dive Into Its Q2 Earnings And Assess The Bad And The Good
Aug 21Medifast, Inc. (NYSE:MED) Analysts Are Reducing Their Forecasts For This Year
Aug 09Are Medifast, Inc. (NYSE:MED) Investors Paying Above The Intrinsic Value?
Jul 27What Does Medifast, Inc.'s (NYSE:MED) Share Price Indicate?
Jul 12Analyse de la situation financière
Passif à court terme: Les actifs à court terme de MED ( $224.3M ) dépassent ses passifs à court terme ( $75.2M ).
Passif à long terme: Les actifs à court terme de MED ( $224.3M ) dépassent ses passifs à long terme ( $13.1M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: MED est sans dette.
Réduire la dette: MED n'avait aucune dette il y a 5 ans.
Couverture de la dette: MED n'a pas de dette, elle n'a donc pas besoin d'être couverte par le flux de trésorerie opérationnel.
Couverture des intérêts: MED n'a aucune dette, par conséquent la couverture des paiements d'intérêts n'est pas un problème.